For Research Use Only. We do not provide direct services or products for patients.
The SARS-CoV-2 (2019-nCoV) S1-RBD IgG/IgM ELISA Detection Kit is designed based on the indirect ELISA and is used for the evaluation of IgG or IgM against SARS-CoV-2 Spike S1-RBD in samples. The kit is for research use only, not for diagnoses.
IgG or IgM antibodies to S1 RBD of SARS-CoV-2 virus
Evaluation of IgG or IgM antibodies against Spike S1-RBD of SARS-CoV-2 in samples.
Store at 2 - 8°C
The 2019 novel coronavirus, or "SARS-CoV-2", was discovered because of Wuhan virus pneumonia cases in 2019, and was named by the World Health Organization on January 12, 2020. It belongs to the beta genera of the Coronaviridae family, together with SARS coronavirus in 2003 and MERS coronavirus in 2012. The alignment between SARS-CoV-2 and 2003 SARS CoV has about 70% sequence similarity and 40% sequence similarity with MERS CoV. The coronavirus genome encodes a spike protein, an envelope protein, a membrane protein, and a nucleoprotein. Among them, spike protein is the most important surface membrane protein of coronavirus.